ZA914435B - Treatment of disease - Google Patents

Treatment of disease

Info

Publication number: ZA914435B
Authority: ZA; South Africa
Prior art keywords: disease; treatment
Prior art date: 1990-06-11

Application number

ZA914435A

Inventor

James Warren Winkelman

Warren Winkelman James

Blaik Phillip Halling

Phillip Halling Blaik

Debra Ann Witkowski

Ann Witkowski Debra

Original Assignee

Fmc Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-11

Filing date

1991-06-10

Publication date

1992-03-25

1991-06-10 Application filed by Fmc Corp filed Critical Fmc Corp

1992-03-25 Publication of ZA914435B publication Critical patent/ZA914435B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA914435A 1990-06-11 1991-06-10 Treatment of disease ZA914435B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53579490A	1990-06-11	1990-06-11

Publications (1)

Publication Number	Publication Date
ZA914435B true ZA914435B (en)	1992-03-25

Family

ID=24135791

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA914435A ZA914435B (en)	1990-06-11	1991-06-10	Treatment of disease

Country Status (7)

Country	Link
AU (1)	AU8185491A (en)
CS (1)	CS176291A3 (en)
IE (1)	IE911971A1 (en)
IL (1)	IL98405A0 (en)
PT (1)	PT97937A (en)
WO (1)	WO1991019418A1 (en)
ZA (1)	ZA914435B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW492975B (en) *	1993-07-26	2002-07-01	Novartis Ag	Tryptase inhibitor
US6023012A (en) *	1996-02-28	2000-02-08	Novartis Finance Corporation	DNA molecules encoding plant protoporphyrinogen oxidase
US5767373A (en)	1994-06-16	1998-06-16	Novartis Finance Corporation	Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US5939602A (en) *	1995-06-06	1999-08-17	Novartis Finance Corporation	DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6084155A (en)	1995-06-06	2000-07-04	Novartis Ag	Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
EP0883682A1 (en) *	1996-02-28	1998-12-16	Novartis AG	Dna molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
CN103694243B (en) *	2013-12-20	2015-09-09	中国农业大学	2-Substituted pyridyl-1,2,4-triazolo[1,2-a]pyridazine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU190371B (en) *	1980-12-18	1986-08-28	The Wellcome Foundation Ltd,Gb	Process for producing ether-type compounds and pharmaceutical compositions containing them as active agents
CA1192545A (en) *	1982-02-16	1985-08-27	Glaxo Group Limited	Heterocyclic derivatives as histamine h.sub.2- antagonists
US5025029A (en) *	1986-10-10	1991-06-18	Children's Hospital Medical Center Of Northern California	Method for augmenting fetal hemoglobin
US4820722A (en) *	1987-08-14	1989-04-11	Eli Lilly And Company	Disubstituted tetrazoles and their use as leukotriene antagonists
US4847276A (en) *	1988-09-06	1989-07-11	Merrell Dow Pharmaceuticals Inc.	Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione

1991
- 1991-06-06 IL IL98405A patent/IL98405A0/en unknown
- 1991-06-10 ZA ZA914435A patent/ZA914435B/en unknown
- 1991-06-10 WO PCT/US1991/004087 patent/WO1991019418A1/en unknown
- 1991-06-10 CS CS911762A patent/CS176291A3/en unknown
- 1991-06-10 IE IE197191A patent/IE911971A1/en unknown
- 1991-06-10 AU AU81854/91A patent/AU8185491A/en not_active Abandoned
- 1991-06-11 PT PT97937A patent/PT97937A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL98405A0 (en)	1992-07-15
CS176291A3 (en)	1992-08-12
IE911971A1 (en)	1991-12-18
PT97937A (en)	1992-04-30
WO1991019418A1 (en)	1991-12-26
AU8185491A (en)	1992-01-07

Publication	Publication Date	Title
AP9000206A0 (en)	1990-10-31	Treatment of conditions & diseases
GB9026278D0 (en)	1991-01-23	Autoimmune disease treatment
GB8928934D0 (en)	1990-02-28	Treatment of birds
GB2243296B (en)	1992-10-21	Treatment of disease associated with hiv-infections
AP9100290A0 (en)	1991-07-31	Pharmaceutical treatment
GB9025710D0 (en)	1991-01-09	Novel treatment
ZA914435B (en)	1992-03-25	Treatment of disease
GB9024928D0 (en)	1991-01-02	Novel treatment
GB9022470D0 (en)	1990-11-28	Treatment of clays
ZA9189B (en)	1991-12-24	Treatment of protozoal diseases
GB9216360D0 (en)	1992-09-16	Treatment of blood
RU1833739C (en)	1993-08-15	Way of treatment hyperekaliemia
GB8829366D0 (en)	1989-02-01	Treatment of disease
GB9024925D0 (en)	1991-01-02	Novel treatment
GB9024926D0 (en)	1991-01-02	Novel treatment
GB9021960D0 (en)	1990-11-21	Treatment of flax
IE901990L (en)	1990-12-02	Treatment of gut disorders
EG20171A (en)	1997-08-31	Treatment of conditions and disease
GB9026067D0 (en)	1991-01-16	Medical treatment
GB9024140D0 (en)	1990-12-19	Medical treatment
GB9008524D0 (en)	1990-06-13	Treatment of cancer
GB9005050D0 (en)	1990-05-02	Treatment of diabetes
GB9026620D0 (en)	1991-01-23	Treatment of lung diseases
IE900102L (en)	1990-07-12	Treatment of skin disorders
RU1833736C (en)	1993-08-15	Means of treatment of psoriasis